Corporate Board Profile
Tech Score: 50/100
2 mention(s) identify RICKY SUN as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| Savara Inc | 2021-04-27 | Dr. Sun received a PhD degree in Chemistry and Chemical Biology from Harvard University and was an NIH post-doctoral fellow in Biological Chemistry & Molecular Pharmacology at Harvard Medical School. | Dr. Sun has a PhD in Chemistry and Chemical Biology and significant experience in life sciences investment; his scientific background and research experience indicate technical skills relevant to software or programming. |
| Savara Inc | 2022-04-19 | Dr. Sun received a Ph.D. in Chemistry and Chemical Biology from Harvard University and was an NIH post-doctoral fellow in Biological Chemistry & Molecular Pharmacology at Harvard Medical School. He also received an M.B.A. from New York University Stern School of Business, where he was a Mildred Elperin Scholar. He graduated summa cum laude from Berea College with a BA in chemistry. Dr. Sun began his career as a Senior Scientist at Ironwood Pharmaceutical where he was involved in the discovery and development of the drug Linzess for irritable bowel syndrome. | Holds a Ph.D. in Chemistry and Chemical Biology, with post-doctoral fellowship in Biological Chemistry & Molecular Pharmacology, and prior experience as a Senior Scientist involved in drug discovery, indicating strong technical and scientific skills potentially including programming. |
| Filing Date | Source Excerpt |
|---|---|
| 2020-04-15 | Dr. Sun received a PhD degree in Chemistry and Chemical Biology from Harvard University and was an NIH post-doctoral fellow in Biological Chemistry & Molecular Pharmacology at Harvard Medical School. We believe that Dr. Sun’s significant experience in the area of life sciences investment qualifies him to serve on our Board of Directors. |
| 2021-04-27 | Dr. Sun received a PhD degree in Chemistry and Chemical Biology from Harvard University and was an NIH post-doctoral fellow in Biological Chemistry & Molecular Pharmacology at Harvard Medical School. |
| 2022-04-19 | Dr. Sun received a Ph.D. in Chemistry and Chemical Biology from Harvard University and was an NIH post-doctoral fellow in Biological Chemistry & Molecular Pharmacology at Harvard Medical School. He also received an M.B.A. from New York University Stern School of Business, where he was a Mildred Elperin Scholar. He graduated summa cum laude from Berea College with a BA in chemistry. Dr. Sun began his career as a Senior Scientist at Ironwood Pharmaceutical where he was involved in the discovery and development of the drug Linzess for irritable bowel syndrome. |
| 2023-04-28 | Dr. Sun received a Ph.D. in Chemistry and Chemical Biology from Harvard University and was an NIH post-doctoral fellow in Biological Chemistry & Molecular Pharmacology at Harvard Medical School. He also received an M.B.A. from New York University Stern School of Business, where he was a Mildred Elperin Scholar. He graduated summa cum laude from Berea College with a BA in chemistry. We believe that Dr. Sun’s significant experience in life sciences investment qualifies him to serve on our Board of Directors. |
Data sourced from SEC filings. Last updated: 2026-02-03